An employee of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for Covid-19 at a laboratory in Tuebingen, Germany. Andreas Gebert / Reuters
An employee of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for Covid-19 at a laboratory in Tuebingen, Germany. Andreas Gebert / Reuters